Delivery Order SPE2DB20D9329-SPE2DB23FZK05

Award Date 2/27/23
Potential Completion Date 2/28/23
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $1,218.30 awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4557390594 - KETAMINE 200 MG/20 ML VIAL 20ML, with a period of performance through June 2, 2022. The award is not associated with a set-aside program and is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,131.54 firm fixed-price delivery order contract is for the supply of 100 grams of Ketamine HCL powder. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order worth $1,134.18 for the supply of 100 grams of Ketamine HCL powder. The contract is a firm fixed-price agreement with no set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award is for the delivery of Ketorolac 30 mg/ml vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,252.32 and is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,880.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 1,000 unit vials of the drug Kcentra. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, for the delivery of 1,000 unit vials of the biologic medication KCENTRA. The contract has a firm fixed-price, delivery order type, with a ceiling value of $58,453.12 and a period of performance through May 13, 2024. The contract is not associated with a set-aside...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,714.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the specialty pharmaceutical product Kcentra. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to...
This federal contract award, valued at $14,637.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order under the DLA's SPE2DB indefinite delivery contract, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. This single-award IDC allows the DLA to issue delivery orders for a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $71,427.84 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the medication KCENTRA, with a completion date of August 14, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows...
This federal contract award is a delivery order issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,225.46, is a firm fixed-price delivery order placed under the Defense Logistics Agency's (DLA) SPE2DB program, a $499,999,999 indefinite delivery contract that runs through December 31, 2025. Under this award, DMS Pharmaceutical Group will supply the DLA with the medication Ketorolac 30 mg/ml...
  • SPE2DB20D9329
    Indefinite Delivery Contract
  • SPE2DB20D9329-SPE2DB23FZK05
    Delivery Order

This federal contract award, valued at $1,232.40, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4560117423 - KETAMINE 500 MG/5 ML VIAL 5ML, with a completion date of February 28, 2023. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 1/9/25, 9:14 AM